Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.

Biswas B, Adhya S, Washart P, Paul B, Trostel AN, Powell B, Carlton R, Merril CR.

Infect Immun. 2002 Jan;70(1):204-10. Erratum in: Infect Immun 2002 Mar;70(3):1664.


Use of bacteriophage in the treatment of experimental animal bacteremia from imipenem-resistant Pseudomonas aeruginosa.

Wang J, Hu B, Xu M, Yan Q, Liu S, Zhu X, Sun Z, Reed E, Ding L, Gong J, Li QQ, Hu J.

Int J Mol Med. 2006 Feb;17(2):309-17.


Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia.

Wang J, Hu B, Xu M, Yan Q, Liu S, Zhu X, Sun Z, Tao D, Ding L, Reed E, Gong J, Li QQ, Hu J.

Int J Mol Med. 2006 Feb;17(2):347-55.


Utility of lytic bacteriophage in the treatment of multidrug-resistant Pseudomonas aeruginosa septicemia in mice.

Vinodkumar CS, Kalsurmath S, Neelagund YF.

Indian J Pathol Microbiol. 2008 Jul-Sep;51(3):360-6.


Bacteriophage control of vancomycin-resistant enterococci in cattle compost.

Otawa K, Hirakata Y, Kaku M, Nakai Y.

J Appl Microbiol. 2012 Sep;113(3):499-507. doi: 10.1111/j.1365-2672.2012.05361.x. Epub 2012 Jul 12.


Combined bacteriophages and antibiotics as an efficient therapy against VRE Enterococcus faecalis in a mouse model.

Gelman D, Beyth S, Lerer V, Adler K, Poradosu-Cohen R, Coppenhagen-Glazer S, Hazan R.

Res Microbiol. 2018 Nov;169(9):531-539. doi: 10.1016/j.resmic.2018.04.008. Epub 2018 May 16.


Identification of ABC transporters in vancomycin-resistant Enterococcus faecium as potential targets for antibody therapy.

Burnie J, Carter T, Rigg G, Hodgetts S, Donohoe M, Matthews R.

FEMS Immunol Med Microbiol. 2002 Jul 12;33(3):179-89.


Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.

Chou YY, Lin TY, Lin JC, Wang NC, Peng MY, Chang FY.

J Microbiol Immunol Infect. 2008 Apr;41(2):124-9.


RelA Mutant Enterococcus faecium with Multiantibiotic Tolerance Arising in an Immunocompromised Host.

Honsa ES, Cooper VS, Mhaissen MN, Frank M, Shaker J, Iverson A, Rubnitz J, Hayden RT, Lee RE, Rock CO, Tuomanen EI, Wolf J, Rosch JW.

MBio. 2017 Jan 3;8(1). pii: e02124-16. doi: 10.1128/mBio.02124-16.


Prevalence of vancomycin-variable Enterococcus faecium (VVE) among vanA-positive sterile site isolates and patient factors associated with VVE bacteremia.

Kohler P, Eshaghi A, Kim HC, Plevneshi A, Green K, Willey BM, McGeer A, Patel SN; Toronto Invasive Bacterial Diseases Network (TIBDN).

PLoS One. 2018 Mar 22;13(3):e0193926. doi: 10.1371/journal.pone.0193926. eCollection 2018.


Intestinal microbiota containing Barnesiella species cures vancomycin-resistant Enterococcus faecium colonization.

Ubeda C, Bucci V, Caballero S, Djukovic A, Toussaint NC, Equinda M, Lipuma L, Ling L, Gobourne A, No D, Taur Y, Jenq RR, van den Brink MR, Xavier JB, Pamer EG.

Infect Immun. 2013 Mar;81(3):965-73. doi: 10.1128/IAI.01197-12. Epub 2013 Jan 14.


Co-colonization of vanA and vanB Enterococcus faecium of clonal complex 17 in a patient with bacteremia due to vanA E. faecium.

Seol CA, Park JS, Sung H, Kim MN.

Diagn Microbiol Infect Dis. 2014 Jun;79(2):141-3. doi: 10.1016/j.diagmicrobio.2014.02.018. Epub 2014 Mar 3.


Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.

Hayakawa K, Marchaim D, Martin ET, Tiwari N, Yousuf A, Sunkara B, Pulluru H, Kotra H, Hasan A, Bheemreddy S, Sheth P, Lee DW, Kamatam S, Bathina P, Nanjireddy P, Chalana IK, Patel S, Kumar S, Vahia A, Ku K, Yee V, Swan J, Pogue JM, Lephart PR, Rybak MJ, Kaye KS.

Antimicrob Agents Chemother. 2012 May;56(5):2452-8. doi: 10.1128/AAC.06299-11. Epub 2012 Feb 21.


[MLST types of vancomycin-resistant Enterococcus faecium strains isolated from blood cultures].

Arslan U, Demir E, Oryaşin E, Türk Dağı H, Tuncer I, Fındık D, Bozdoğan B.

Mikrobiyol Bul. 2013 Jul;47(3):432-41. Turkish.


Treatment options for vancomycin-resistant enterococcal infections.

Linden PK.

Drugs. 2002;62(3):425-41. Review.


Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.

Ghanem G, Hachem R, Jiang Y, Chemaly RF, Raad I.

Infect Control Hosp Epidemiol. 2007 Sep;28(9):1054-9. Epub 2007 Jul 12.


Experimental protection of diabetic mice against Lethal P. aeruginosa infection by bacteriophage.

Shivshetty N, Hosamani R, Ahmed L, Oli AK, Sannauallah S, Sharanbassappa S, Patil SA, Kelmani CR.

Biomed Res Int. 2014;2014:793242. doi: 10.1155/2014/793242. Epub 2014 Jun 5.


[Evaluation of virulence factors in enterococcus species].

Mete E, Kaleli İ, Cevahir N, Demir M, Akkaya Y, Kiriş Satılmış Ö.

Mikrobiyol Bul. 2017 Apr;51(2):101-114. Turkish.


A method for generation phage cocktail with great therapeutic potential.

Gu J, Liu X, Li Y, Han W, Lei L, Yang Y, Zhao H, Gao Y, Song J, Lu R, Sun C, Feng X.

PLoS One. 2012;7(3):e31698. doi: 10.1371/journal.pone.0031698. Epub 2012 Mar 1.

Supplemental Content

Support Center